BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37577090)

  • 1. Bioanalysis of MMR and KRAS - a key factor in diagnosis of colorectal cancer.
    Stefan-van Staden RI; Bratei AA; Ilie-Mihai RM; Gheorghe DC; Tuchiu BM; Gurzu S
    RSC Adv; 2023 Aug; 13(34):24086-24092. PubMed ID: 37577090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New stochastic devices for simultaneous analysis of mismatch repair proteins and KRAS in biological samples.
    Stefan-van Staden RI; Bratei AA; Ilie-Mihai RM; Gheorghe DC; Tuchiu BM
    J Pharm Biomed Anal; 2023 Oct; 235():115630. PubMed ID: 37643504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 4. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
    Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
    World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.
    Giráldez MD; Balaguer F; Bujanda L; Cuatrecasas M; Muñoz J; Alonso-Espinaco V; Larzabal M; Petit A; Gonzalo V; Ocaña T; Moreira L; Enríquez-Navascués JM; Boland CR; Goel A; Castells A; Castellví-Bel S
    Clin Cancer Res; 2010 Nov; 16(22):5402-13. PubMed ID: 20924129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 9. Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes.
    Reitsam NG; Märkl B; Dintner S; Waidhauser J; Vlasenko D; Grosser B
    Front Oncol; 2022; 12():1019798. PubMed ID: 36387226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of the Immunohistochemical Expression of Mismatch Repair Proteins (MSH2, MSH6, MLH1, and PMS2) in Prostate Adenocarcinoma.
    Javeed S; Chughtai A; Zafar G; Khalid F; Batool A; Chughtai AS
    Cureus; 2022 Jul; 14(7):e27448. PubMed ID: 36051725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression status of four mismatch repair proteins in patients with colorectal cancer: clinical significance in 1238 cases.
    Chen L; Chen G; Zheng X; Chen Y
    Int J Clin Exp Pathol; 2019; 12(10):3685-3699. PubMed ID: 31933757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
    Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
    Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair.
    DuPrie ML; Palacio T; Calil FA; Kolodner RD; Putnam CD
    DNA Repair (Amst); 2022 Nov; 119():103405. PubMed ID: 36122480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma.
    Kaur G; Masoud A; Raihan N; Radzi M; Khamizar W; Kam LS
    Indian J Med Res; 2011 Aug; 134(2):186-92. PubMed ID: 21911971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review.
    Li J; Xu Q; Luo C; Chen L; Ying J
    Medicine (Baltimore); 2020 Jun; 99(24):e20554. PubMed ID: 32541478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
    Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
    PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Mismatch Repair-Deficient Colon Cancer in Relation to Mismatch Repair Protein Loss, Hypermethylation Silencing, and Constitutional and Biallelic Somatic Mismatch Repair Gene Pathogenic Variants.
    Keshinro A; Ganesh K; Vanderbilt C; Firat C; Kim JK; Chen CT; Yaeger R; Segal NH; Gonen M; Shia J; Stadler ZK; Weiser MR
    Dis Colon Rectum; 2023 Apr; 66(4):549-558. PubMed ID: 35724254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.